Investigators conducted a systematic review assessing the efficacy of positive psychology interventions for patients and survivors across various stages and types of cancer.
(HealthDay News) — Regular physical activity can significantly reduce cancer-related fatigue and improve quality of life in people with colorectal cancer, according to a study presented at the ...
In this analysis, researchers aimed to investigate associations between preservative intake and cancer incidence in a large prospective cohort.
Nurses at hospitals across NYC are on strike in hopes of higher pay and safer working environments, among other things. (HealthDay News) — Thousands of nurses at several major New York City hospitals ...
Men are twice as likely as women to have stage III multiple myeloma at diagnosis and appear to have a greater tumor burden than women, according to ...
Although 76% respondents reported encountering medical misinformation, that exposure was not significantly associated with clinically significant fear of cancer recurrence or self-reported treatment ...
Gathering first-degree family histories for patients with childhood cancers through currently available questions and a personal history is sufficient to ...
Investigators evaluated the efficacy and safety of toripalimab versus dacarbazine as the first-line treatment in advanced melanoma predominantly of acral subtype.
In this analysis, researchers aimed to evaluate the clinicopathologic characteristics, metastatic patterns, and survival outcomes in patients with metastatic prostate cancer and low-volume primary ...
Intensity-modulated proton therapy (IMPT) improves overall survival (OS) and reduces high-grade toxicity compared with intensity-modulated radiation ...
In May, the U.S. Food and Drug Administration (FDA) approved the first at-home cervical cancer screening tool, developed by Teal Health. The wand allows patients to collect a vaginal sample themselves ...
The Food and Drug Administration (FDA) has approved Rybrevant Faspro™, a subcutaneous (SC) formulation of amivantamab for all indications approved for the ...